Trader consensus on Polymarket reflects a 93.5% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as an acquirer rather than a target. Recent moves include its $400 million stock acquisition of biotech startup Coefficient Bio in early April 2026 to bolster AI-driven drug discovery, following purchases of developer tool Bun in December 2025 and computer-use specialist Vercept in February 2026. A massive $30 billion Series G funding round in February valued Anthropic at $380 billion post-money, underscoring financial independence backed by deep Amazon and Google partnerships without full ownership transfer. CEO Dario Amodei's public commitments to autonomy and reports of IPO exploration further solidify this positioning. While regulatory scrutiny or unforeseen cash burn could prompt a surprise bid, current momentum favors standalone growth amid competitive AI scaling.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$15,454 Vol.
$15,454 Vol.
Dec 31, 2026
$15,454 Vol.
$15,454 Vol.
Dec 31, 2026
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 93.5% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as an acquirer rather than a target. Recent moves include its $400 million stock acquisition of biotech startup Coefficient Bio in early April 2026 to bolster AI-driven drug discovery, following purchases of developer tool Bun in December 2025 and computer-use specialist Vercept in February 2026. A massive $30 billion Series G funding round in February valued Anthropic at $380 billion post-money, underscoring financial independence backed by deep Amazon and Google partnerships without full ownership transfer. CEO Dario Amodei's public commitments to autonomy and reports of IPO exploration further solidify this positioning. While regulatory scrutiny or unforeseen cash burn could prompt a surprise bid, current momentum favors standalone growth amid competitive AI scaling.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Market Opened: Nov 12, 2025, 5:14 PM ET
Volume
$15,454End Date
Dec 31, 2026Market Opened
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 93.5% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as an acquirer rather than a target. Recent moves include its $400 million stock acquisition of biotech startup Coefficient Bio in early April 2026 to bolster AI-driven drug discovery, following purchases of developer tool Bun in December 2025 and computer-use specialist Vercept in February 2026. A massive $30 billion Series G funding round in February valued Anthropic at $380 billion post-money, underscoring financial independence backed by deep Amazon and Google partnerships without full ownership transfer. CEO Dario Amodei's public commitments to autonomy and reports of IPO exploration further solidify this positioning. While regulatory scrutiny or unforeseen cash burn could prompt a surprise bid, current momentum favors standalone growth amid competitive AI scaling.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Volume
$15,454End Date
Dec 31, 2026Market Opened
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects a 93.5% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as an acquirer rather than a target. Recent moves include its $400 million stock acquisition of biotech startup Coefficient Bio in early April 2026 to bolster AI-driven drug discovery, following purchases of developer tool Bun in December 2025 and computer-use specialist Vercept in February 2026. A massive $30 billion Series G funding round in February valued Anthropic at $380 billion post-money, underscoring financial independence backed by deep Amazon and Google partnerships without full ownership transfer. CEO Dario Amodei's public commitments to autonomy and reports of IPO exploration further solidify this positioning. While regulatory scrutiny or unforeseen cash burn could prompt a surprise bid, current momentum favors standalone growth amid competitive AI scaling.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions